3D Cell Culture Conference

Development and application of human organs and tissues in vitro


London, United Kingdom

Cell Culture in an important tool for research and development within the life science industry. The global 3D Cell Culture Market market is valued at USD 1069.28 Million and is expected to grow with a CAGR of 25.31% over the forecast period. Researchers globally are realizing the potential of 3D cell culture for various applications, including models for personalized medicine, complex and multi-cell type models, translation and clinical and industrial applications.

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

Our 3D Cell Culture conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

Benefits of Attending

  • Learn from leading pharma companies to benchmark against their applications of 3D technology
  • Explore case studies of 3D cell culture, high throughput screening, imaging and microphysiological systems in industry
  • Hear about the latest technology advances allowing 3D bioprinting to revolutionize in vitro models
  • Network with the key industry players developing the use of bioprinting as part of their R&D
  • Understand novel applications of 3D bioprinting for in vitro models, regenerative medicine and screening

Who should attend

Executives, Directors, VPs, Heads, Principals, Managers of:
  • Cell Technology
  • Lab Head Lead Discovery
  • High Throughput Screening
  • Research and Development
  • Disease Models
  • Cell Biology & Tissue Engineering
  • Translational Science
  • Complex In Vitro Models
  • Cell and Molecular Scientist
  • Systems Biology
  • Drug Discovery

Plus a Pre-Conference Focus Day: 18th February

3D Bioprinting
Chair: Jason Ekert, Head of Complex In Vitro Models,GSK

Speakers

  • Alexander D. Graham, Investigator Scientist, MRC Harwell Institute
  • Asli Akidil, Cell and Molecular Scientist, AstraZeneca
  • Ellen J Wehrens, Scientific Writer, Princess Maxima Center
  • Floriane Groell, (Research Associate of the) Biopharmaceutical Sciences department, University of Geneva
  • Jason Ekert, Head of Complex In Vitro Models, GlaxoSmithKline
  • Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University
  • Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, Medicines & Healthcare products Regulatory Agency (MHRA)
  • Maxime Feyeux, Co-Founder, President, CSO, TreeFrog Therapeutics
  • Michele Zagnoni, Senior Lecturer, University Of Strathclyde
  • Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
  • Rajesh Pandey, Postdoctoral Training Fellow, MRC Harwell Institute
  • Rhiannon David, Associate Principal Scientist, AstraZeneca
  • Samuel Jackson, Programme Manager, Disease Models, NC3Rs
  • Simone Stahl, Associate Principal Scientist, AstraZeneca
  • Stefan Przyborski, Professor of Cell Technology, Durham University
  • Veronique Barban, Expert Virology, Sanofi Pasteur
  • Wendy Rowan, Scientific Director, GSK

Please fill in your name and email to receive the Conference Agenda of this event.

Venue

Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK